Inside the research
Schrödinger, Inc.
SDGR Research profile · latest available data
Price overview
$28.85
▼ -0.60 (-2.0%)
| 52w hi | $30.70 |
|---|---|
| 52w lo | $11.07 |
| Vol | 1.37M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.21
| Short | +0.51 |
|---|---|
| Medium | +0.28 |
| Long | -0.54 |
computed 2026-09-27
Key fundamentals
Schrödinger, Inc.
Healthcare · Health Information Services
| Market cap | $2.16B |
|---|---|
| Enterprise value | $1.85B |
| Forward P/E | -21.37x |
| EV / EBITDA | -12.55x |
| P / S (ttm) | 8.33x |
| Profit margin | -21.0% |
| Return on equity | -16.2% |
| Revenue growth | +7.5% |
| Debt / equity | 32.83 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.14 | |
| Sector | +0.08 | |
| Technical | +0.33 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Risk Metrics
| Beta vs SPX | 1.49 |
|---|---|
| Corr SPX | 0.38 |
| Annual vol | 62.8% |
| Annual ret | +37.8% |
| Sharpe | 0.60 |
| Max DD | -58.5% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-05 | Earnings Release, Exhibits | read |
| 2026-06-29 | Reg FD Disclosure | read |
| 2026-06-23 | Officer / Director Change, Shareholder Vote… | read |
| 2026-06-08 | Officer / Director Change, Exhibits | read |
| 2026-05-20 | Officer / Director Change, Reg FD Disclosure | read |
| 2026-05-05 | Earnings Release, Exhibits | read |
| 2026-03-12 | Officer / Director Change | read |
| 2026-02-25 | Earnings Release, Exhibits | read |
| 2025-11-05 | Earnings Release, Exhibits | read |
| 2025-09-08 | Officer / Director Change, Exhibits | read |
| 2025-08-06 | Earnings Release, Exhibits | read |
| 2025-06-18 | Shareholder Vote | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | Jain Rachit | EVP & CFO | Sell | 875 | $13.65K |
| 2026-06-26 | Friesner Richard | Gift | 679.37K | — | |
| 2026-06-22 | OBEROI ARUN | Grant | 8.14K | — | |
| 2026-06-22 | Chodakewitz Jeffrey | Grant | 8.14K | — | |
| 2026-06-22 | Friesner Richard | Grant | 8.14K | — | |
| 2026-06-22 | GINSBERG GARY L | Grant | 8.14K | — | |
| 2026-06-22 | Kapeller-Libermann Rosana | Grant | 8.14K | — | |
| 2026-06-22 | Lynton Michael | Grant | 8.14K | — | |
| 2026-06-22 | Sender Gary | Grant | 8.14K | — | |
| 2026-06-22 | Thornberry Nancy | Grant | 8.14K | — |
Flow & Concentration
| Insider 180d net | -$13.65K |
|---|---|
| Insider buys / sells | 0 / 1 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 99.9% |
| HHI | 2,233 (moderate) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $37.35M | 2.30M |
| Ark Invest | $35.00M | 2.15M |
| AQR Capital Management | $31.79M | 1.96M |
| Citadel Advisors | $16.00M | 984.78K |
| Capital Research / Capital World | $15.67M | 964.13K |
| Fidelity / FMR LLC | $199.98K | 12.31K |
| T. Rowe Price Group | $1.77K | 109.04K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2020–2025 · 6 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $207.54M | +19.4% | |
| Gross profit | $142.61M | +23.8% | |
| Operating income | -$166.90M | — | |
| Net income | -$103.27M | +0.0% | |
| Cash from ops | -$136.73M | — |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $29.60 | $29.74 | $27.69 | $28.85 | 1.37M |
| Sep 24 | $28.97 | $30.24 | $28.40 | $29.45 | 2.03M |
| Sep 23 | $30.05 | $31.14 | $28.32 | $29.23 | 3.07M |
| Sep 22 | $30.13 | $31.59 | $29.69 | $30.70 | 2.58M |
| Sep 21 | $29.43 | $31.03 | $29.00 | $30.24 | 2.89M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →